Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis
- PMID: 780279
- PMCID: PMC420844
- DOI: 10.1128/iai.14.1.62-67.1976
Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis
Abstract
The effects of cryptococcal polysaccharide and selected serum factors on (i) the attachment of Cryptococcus neoformans to macrophages and (ii) the subsequent ingestion of yeast cells by the macrophages were investigated. Percent attachment was measured after incubation of yeast cells with macrophages at 4 C. Percent engulfment was determined after incubation of yeast cells and macrophages at 37 C. Nonencapsulated yeast cells readily attached to macrophages at the low temperature and were engulfed at a high rate at 37 C, whereas encapsulated yeast cells attached to macrophages at low rates and were engulfed at low rates. Addition of varying doses of purified cryptococcal polysaccharide to nonencapsulated yeast cells inhibited attachment at approximately the same concentration of polysaccharide required for inhibition of engulfment. Nonencapsulated yeast cells that attached to macrophages at 4 C were eluted from the macrophages by addition of purified cryptococcal polysaccharide to the incubation medium. Heat-labile opsonins were not required for attachment of yeast cells to macrophages, but they were necessary for maximal initial rates of phagocytosis. Heat-stable components of serum facilitated attachment of cryptococci, but their most important function appeared to be triggering the ingestion of attached yeast. Specific antiserum had no effect on the attachment and engulfment of nonencapsulated cryptococci, and the antiserum produced only a small enhancement of the engulfment of encapsulated cryptococci.
Similar articles
-
Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide.Infect Immun. 1977 Apr;16(1):99-106. doi: 10.1128/iai.16.1.99-106.1977. Infect Immun. 1977. PMID: 326680 Free PMC article.
-
Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.Infect Immun. 1981 Mar;31(3):978-84. doi: 10.1128/iai.31.3.978-984.1981. Infect Immun. 1981. PMID: 7014468 Free PMC article.
-
Opsonization of Cryptococcus neoformans by human immunoglobulin G: masking of immunoglobulin G by cryptococcal polysaccharide.Infect Immun. 1979 Jul;25(1):262-7. doi: 10.1128/iai.25.1.262-267.1979. Infect Immun. 1979. PMID: 383615 Free PMC article.
-
Role of the capsule in phagocytosis of Cryptococcus neoformans.Rev Infect Dis. 1988 Jul-Aug;10 Suppl 2:S436-9. doi: 10.1093/cid/10.supplement_2.s436. Rev Infect Dis. 1988. PMID: 3055212 Review.
-
Receptor-mediated recognition of Cryptococcus neoformans.Nihon Ishinkin Gakkai Zasshi. 2002;43(3):133-6. doi: 10.3314/jjmm.43.133. Nihon Ishinkin Gakkai Zasshi. 2002. PMID: 12145626 Review.
Cited by
-
An overview of macrophage-fungal interactions.Mycopathologia. 1986 Feb;93(2):77-93. doi: 10.1007/BF00437738. Mycopathologia. 1986. PMID: 3520327 Review.
-
Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses.Infect Immun. 1991 Nov;59(11):3883-8. doi: 10.1128/iai.59.11.3883-3888.1991. Infect Immun. 1991. PMID: 1937747 Free PMC article.
-
Cryptococcus gattii: An Emerging Cause of Fungal Disease in North America.Interdiscip Perspect Infect Dis. 2009;2009:840452. doi: 10.1155/2009/840452. Epub 2009 May 25. Interdiscip Perspect Infect Dis. 2009. PMID: 19503836 Free PMC article.
-
Immunity in cryptococcosis: an overview.Mycopathologia. 1982 Mar 19;77(3):183-90. doi: 10.1007/BF00518804. Mycopathologia. 1982. PMID: 7040977 Review.
-
What makes Cryptococcus neoformans a pathogen?Emerg Infect Dis. 1998 Jan-Mar;4(1):71-83. doi: 10.3201/eid0401.980109. Emerg Infect Dis. 1998. PMID: 9452400 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources